Shortage reporting & other issues that good data could solve right now

The fact that Life Sciences is now adopting and seeing value in structured data is a huge turning point for the industry, and this acceptance is becoming increasingly palpable. Once companies are able to see beyond the mandatory detail of the regulations that are helping to drive data-oriented process change, their opportunities for transformation of entire functions and their approaches to product tracking and management will broaden and multiply.

Certainly, harnessing structured data and using this for strategic advantage is about so much more than adhering to the specific requirements of IDMP, ePI, CTIS, ESMP, PQ/CMC and associated global implementation projects for their own sake. Access to good-quality data can help to significantly improve internal and external processes – with a view to identifying new market openings, optimizing clinical trials, shortening time to market, eliminating product shortages, and managing labelling changes seamlessly and without fuss.